Affirm (NASDAQ:AFRM - Get Free Report) was upgraded by analysts at Citizens Jmp from a "hold" rating to a "strong-buy" rating in a research note issued on Friday,Zacks.com reports.
AFRM has been the topic of several other research reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Affirm in a research note on Friday, September 6th. The Goldman Sachs Group increased their target price on shares of Affirm from $57.00 to $78.00 and gave the stock a "buy" rating in a research report on Monday, December 2nd. Jefferies Financial Group upgraded shares of Affirm from a "hold" rating to a "buy" rating and boosted their price target for the company from $70.00 to $82.00 in a research report on Thursday. Susquehanna raised their price objective on shares of Affirm from $52.00 to $57.00 and gave the stock a "positive" rating in a report on Friday, November 8th. Finally, Bank of America boosted their target price on Affirm from $50.00 to $74.00 and gave the stock a "buy" rating in a report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, six have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $60.94.
Get Our Latest Stock Analysis on AFRM
Affirm Stock Performance
AFRM traded up $2.64 on Friday, hitting $65.64. 8,695,380 shares of the stock traded hands, compared to its average volume of 9,024,092. The business has a fifty day moving average price of $57.45 and a two-hundred day moving average price of $41.90. The company has a current ratio of 12.60, a quick ratio of 12.60 and a debt-to-equity ratio of 2.50. The firm has a market capitalization of $20.61 billion, a PE ratio of -46.23 and a beta of 3.66. Affirm has a 52 week low of $22.25 and a 52 week high of $73.34.
Affirm (NASDAQ:AFRM - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.31) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.05. The company had revenue of $698.48 million for the quarter, compared to analyst estimates of $661.39 million. Affirm had a negative return on equity of 12.57% and a negative net margin of 17.67%. During the same quarter last year, the firm earned ($0.57) EPS. On average, research analysts predict that Affirm will post -0.53 EPS for the current fiscal year.
Insider Transactions at Affirm
In other Affirm news, CFO Robert O'hare sold 100,938 shares of the firm's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $55.00, for a total transaction of $5,551,590.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Katherine Adkins sold 200,000 shares of the company's stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $55.05, for a total value of $11,010,000.00. Following the completion of the sale, the insider now directly owns 93,545 shares of the company's stock, valued at approximately $5,149,652.25. This trade represents a 68.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,300,851 shares of company stock worth $84,875,518 in the last quarter. 12.41% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the company. KBC Group NV boosted its position in shares of Affirm by 3.6% during the third quarter. KBC Group NV now owns 6,331 shares of the company's stock worth $258,000 after purchasing an additional 222 shares in the last quarter. CIBC Asset Management Inc lifted its holdings in Affirm by 3.2% during the third quarter. CIBC Asset Management Inc now owns 7,520 shares of the company's stock worth $307,000 after acquiring an additional 233 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Affirm by 82.4% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,195 shares of the company's stock valued at $36,000 after acquiring an additional 540 shares during the period. Myecfo LLC grew its stake in Affirm by 5.0% in the third quarter. Myecfo LLC now owns 12,260 shares of the company's stock valued at $500,000 after acquiring an additional 589 shares during the period. Finally, Advisors Asset Management Inc. increased its holdings in shares of Affirm by 168.2% in the third quarter. Advisors Asset Management Inc. now owns 1,070 shares of the company's stock worth $44,000 after acquiring an additional 671 shares in the last quarter. Institutional investors and hedge funds own 69.29% of the company's stock.
Affirm Company Profile
(
Get Free Report)
Affirm Holdings, Inc operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.
Read More
Before you consider Affirm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Affirm wasn't on the list.
While Affirm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.